Recent Advances in Animal Models of Neuropsychiatric Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 25 December 2026
Editor
Interests: neurophysiology; neurodegeneration; animal behaviour; molecular biology; molecular genetics; oxidative stress
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
As a Guest Editor of Pharmaceuticals, it is my pleasure to invite you to contribute to the current Special Issue, which will focus on recent advances in animal models of neuropsychiatric diseases. We invite the submission of original research and reviews that describe novel approaches and updates to animal models of neuropsychiatric diseases. Contributions should align with the general scope of Pharmaceuticals, which includes modelling psychiatric symptoms and describing drug responses in neuropsychiatric diseases defined by the DSM-5. However, innovative and interdisciplinary approaches are welcomed and encouraged, and it is our goal to establish the exchange of high-quality scientific information between experts.
Dr. Ioana-Miruna Balmus
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuropsychiatric diseases
- DSM-5
- ageing
- neurodegeneration
- affective disorders
- neurodevelopmental disorders
- schizophrenia
- trauma and stress
- sleep disorders
- animal models
- in vivo models
- in vitro models
- pharmacodynamics
- innovative therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
